A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
11/1992
11/26/1992	CA2086327A1 Cloning and recombinant production of receptor(s) of the activin/tgf- .beta. superfamily
11/25/1992	WO1992020700A1 UNSATURATED 17β-SUBSTITUTED 3-CARBOXY STEROIDS
11/25/1992	EP0515313A2 Somatostatin analogues containing chelating groups and their radiolabeled compositions
11/25/1992	EP0515140A1 Amide esters of rapamycin
11/25/1992	EP0514935A1 Novel benzopyran derivatives and processes for the preparation thereof
11/25/1992	EP0514721A1 Peptides having thrombospondin-like activity and their therapeutic use
11/25/1992	EP0514720A2 Bone growth factors and inhibitors of bone resorption for promoting bone formation
11/25/1992	EP0514603A1 Viral mediated destruction of neoplastic cells
11/25/1992	EP0514464A1 Biologically active amphiphilic peptides and method of inhibiting growth of target cells, virus or virally-infected cell
11/25/1992	CA2087953A1 Unsaturated 17.beta. -substituted 3-carboxy steroids
11/24/1992	US5166201 2β,19-ethylene bridged steroids as aromatase inhibitors
11/24/1992	US5166152 Immunostimulants, bactericides, viricides, antitumor agents
11/24/1992	US5165922 Treatment of breast cancer
11/24/1992	CA1310637C Epipodophyllotoxin glucoside 4'-phosphate derivatives
11/23/1992	CA2063055A1 Peptides having thrombospondin-like activity and their therapeutic use
11/21/1992	CA2068567A1 Amide esters of rapamycin
11/19/1992	EP0514269A1 Imino-derivatives, process for their preparation and their use in human and veterinary medicine and in cosmetics
11/19/1992	EP0514264A1 Biaromatic compounds derived from compounds having a salicylic configuration, their preparation process and their use in human and veterinary medicine and in cosmetics
11/19/1992	EP0514126A1 Benzodiazepine analogs
11/19/1992	EP0514125A1 Triazolobenzodiazepines
11/19/1992	EP0513917A1 Antiviral combinations containing nucleoside analogs
11/19/1992	EP0513878A2 Pharmaceutical compositions containing cationic surfactants
11/19/1992	EP0513675A1 New peptide compound and a process for the preparation thereof
11/19/1992	EP0513351A1 2-nitroimidazole derivative, production thereof, and radiosensitizer containing the same as active ingredient
11/19/1992	EP0513336A1 New variants derived from interferons of type i, production process thereof and their applications
11/18/1992	WO1992020364A1 Cytokine receptor targeted molecules for treatment of meoplastic cell growth
11/18/1992	CN1066268A Process for preparation of 4'-demethylepipodophyllotoxin glucoside 4'-phosphates
11/18/1992	CA2103258A1 Cytokine receptor targeted molecules for treatment of neoplastic cell growth
11/17/1992	WO1992020372A1 Method of suppressing tumor formation in vivo by administering je/mlp-1
11/17/1992	US5164526 Pleuromutilins
11/17/1992	US5164414 Antitumor
11/17/1992	CA2109315A1 Method of suppressing tumor formation in vivo by administering je/mlp-1
11/17/1992	CA1310445C Derivatives of aminopimelic acid, process for their preparation and their application as medecines
11/17/1992	CA1310443C Glutamic acid derivatives, their salts, process of preparation, applications as medications, and compositions containing them
11/17/1992	CA1310264C Modified antibodies for enhanced clearance
11/16/1992	CA2068696A1 Imine-derived aromatic compounds, process for their preparation and their use in human and veterinary medecine, and in cosmetics
11/15/1992	CA2068434A1 Benzodiazepine analogs
11/15/1992	CA2068433A1 Triazolobenzodiazepines
11/14/1992	CA2068478A1 Peptide compound and a process for the preparation thereof
11/12/1992	WO1992019767A1 Methods to profile and treat abnormal cells
11/12/1992	WO1992019759A1 Reconstituted human antibody against human interleukin 6 receptor
11/12/1992	WO1992019736A1 Growth hormone antagonists
11/12/1992	WO1992019735A1 GLYCAM-1 (Sgp 50), A SELECTIN LIGAND
11/12/1992	WO1992019733A1 Thyroidal receptor for n-acetylglucosamine
11/12/1992	WO1992019651A1 Luteinizing hormone releasing hormone antagonist peptides
11/12/1992	WO1992019639A1 Glycosylated prodrugs, method of preparation and use
11/12/1992	WO1992019613A2 1,2-dithiole-3-thione derivative-based therapeutical compositions
11/12/1992	WO1992019266A1 Recombinant virus expressing carcinoembryonic antigen and methods of use thereof
11/12/1992	WO1992019262A1 Bone growth factors and inhibitors of bone resorption for promoting bone formation
11/12/1992	WO1992019252A1 Antisense oligonucleotides to c-kit proto-oncogene and uses thereof
11/12/1992	WO1992019105A1 Cell differentiation induction with mevalonate and mevalonolactone derivatives
11/12/1992	CA2109120A1 Cell differentiation induction with mevalonate and mevalonolactone derivatives
11/12/1992	CA2108029A1 Glycam-1(sgp 50), a selectin ligand
11/12/1992	CA2107915A1 Antisense oligonucleotides to c-kit proto-oncogene and uses thereof
11/11/1992	WO1992020358A1 Novel biologically active peptide compositions and uses therefor
11/11/1992	EP0512905A2 Heterobifunctional antibodies possessing both catalytic and specific antigen binding properties and methods using them
11/11/1992	EP0512849A1 Use of deacylated chitin derivatives for the treatment of tumours of the haemopoietic system
11/11/1992	EP0512102A1 Proteins purified from mammalian gestational tissue which control cell proliferation
11/11/1992	EP0512076A1 Method of treating cancer using structured lipids
11/11/1992	EP0303687B1 Compositions for enhancing adcc therapy
11/11/1992	CA2086111A1 Biologically active peptide compositions and uses therefor
11/10/1992	US5162532 Intermediates and method of making camptothecin and camptothecin analogs
11/10/1992	US5162335 Di- and tetrahydroisoquinoline derivatives
11/10/1992	US5162330 Dynemicin c antibiotic, its triacetyl derivative and pharmaceutical composition containing same
11/10/1992	US5162320 1,4-bis(alkylamino)-2,3-diaza-anthracene-9,10-diones
11/10/1992	US5162312 11β-substituted 16α, 17α-methylene-estra-4,9-dien-3-ones
11/04/1992	WO1992019752A1 Rna delivery vector
11/04/1992	EP0511917A1 Glycosylated prodrugs, process for their preparation and uses thereof
11/04/1992	EP0511792A2 Pyridoprimidine derivatives as antineoplastic agents
11/04/1992	EP0511747A1 Hybrid polypeptide containing an avidin binding polypeptide
11/04/1992	EP0511563A1 Process for the preparation of 4'-demethylepipodophyllotoxin glucoside 4'-phosphates
11/04/1992	EP0511306A1 Tumor killing effects of enterotoxins and related compounds
11/04/1992	EP0498843A4 Oligonucleotide analogs with novel linkages
11/04/1992	CN1065863A Pyrimidine derivatives for enhancing antitumor activity
11/04/1992	CA2086510A1 Rna delivry vector
11/03/1992	WO1992019594A1 Pyrrolidinones
11/03/1992	US5160727 Tumor cell sensitization method using quinazolinedione derivatives
11/03/1992	US5160725 Magnetic liquid compositions
11/03/1992	CA2102106A1 Pyrrolidinones
11/03/1992	CA1309717C Promoting agents of the activity of some antitumor agents against various kinds of tumor cells including multiple drug resistant tumor cells andtheir synthetic methods
10/1992
10/31/1992	WO1992019632A1 Trifluoromethyl analogs of fucose and uses thereof
10/31/1992	CA2106785A1 Trifluoromethyl analogs of fucose and uses thereof
10/30/1992	CA2066898A1 Pharmaceutical compounds
10/30/1992	CA2062510A1 Process for the preparation of 4'-demethylepipodophyllotoxin gluoside 4'-phosphates
10/29/1992	WO1992018536A2 Method for detecting an localizing tissues having neurokinine 1 receptors
10/29/1992	WO1992018534A1 Minimum recognition unit of a pem mucin tandem repeat specific monoclonal antibody
10/29/1992	WO1992018530A1 SYNTHETIC CDw52(CAMPATH-1) PEPTIDE ANTIGEN
10/29/1992	WO1992018512A1 Aminoacyl derivatives of gem-diphosphonic acids, a process for the preparation thereof and pharmaceutical compositions containing them
10/29/1992	WO1992018511A1 Gem-diphosphonic acid nitrosocarbamoyl derivatives, a process for the preparation thereof and pharmaceutical compositions containing them
10/29/1992	WO1992018485A1 Anti-cancer coumpounds
10/29/1992	WO1992018469A1 Anti-cancer antracene derivatives
10/29/1992	WO1992018465A1 Compounds for inhibition of protein methylation
10/29/1992	WO1992018152A1 Use of müllerian inhibiting substance for treatment of certain tumors
10/29/1992	WO1992018131A1 Method for potentiating primary drugs in treating multidrug resistant cells
10/29/1992	WO1992018089A2 Use of steroidal and non-steroidal amines to sensitize multidrug-resistant cells
10/29/1992	WO1992016623A3 Receptors for bombesin-like peptides
10/29/1992	WO1992015601A3 Heteroanthracycline antitumor analogs
10/29/1992	CA2108264A1 Use of mullerian inhibiting substance for treatment of certain tumors
10/29/1992	CA2108256A1 Anti-cancer compounds
10/29/1992	CA2108255A1 Anti-cancer compounds

1 ... 2134 2135 2136 2137 2138 2139 2140 2141 2142 2143 2144 2145 2146 2147 2148 2149 2150 2151 2152 2153 2154 ... 2211